Cobalamin Status In Patients With Type 2 Diabetes Mellitus At Primary Health Care Centers In Bahrain - A Cross-Sectional Study

Background and Objectives: Cobalamin, also known as vitamin B12, is essential for DNA synthesis and neurological functioning. Deficiency results in hematological and neurocognitive manifestations. One risk factor for vitamin B12 deficiency is the use of metformin, a common oral hypoglycemic agent. T...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahmood A Alawainati (Author), Zahra A Ayoob (Author), Huda S Naser (Author)
Format: Book
Published: Bahrain Medical Society, 2024-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c8ab8b2de83b4591b96e555cfc2db2aa
042 |a dc 
100 1 0 |a Mahmood A Alawainati  |e author 
700 1 0 |a Zahra A Ayoob  |e author 
700 1 0 |a Huda S Naser  |e author 
245 0 0 |a Cobalamin Status In Patients With Type 2 Diabetes Mellitus At Primary Health Care Centers In Bahrain - A Cross-Sectional Study 
260 |b Bahrain Medical Society,   |c 2024-01-01T00:00:00Z. 
500 |a 1015-6321 
500 |a 2960-6004 
500 |a 10.26715/jbms.36_1_1 
520 |a Background and Objectives: Cobalamin, also known as vitamin B12, is essential for DNA synthesis and neurological functioning. Deficiency results in hematological and neurocognitive manifestations. One risk factor for vitamin B12 deficiency is the use of metformin, a common oral hypoglycemic agent. This study was conducted to determine cobalamin status in patients with type 2 diabetes mellitus at primary health care centers in Bahrain. Methods: This cross-sectional study was conducted in five randomly selected health centers in Bahrain. Vitamin B12 levels below 148 pmol/L were categorized as deficient, levels ranging from 148 to 221 pmol/L were considered borderline, and levels exceeding 221 pmol/L were classified as normal. Results: A total of 691 participants were included in the study, with a mean age of 58.7 years. The most common comorbid condition among our cohort was hypertension (63.1%), followed by dyslipidemia (53.1%). Analysis of the glycemic control showed that only 40% of the participants achieved control targets. Nearly 10% (9.4%, n=65) of the cohort had low levels of vitamin B12, and 31% had borderline values. A significant association was seen between low vitamin B12 levels and Bahraini nationality (P<0.001), and patients who engaged in weekly exercise (P=0.007). Furthermore, the analysis revealed that the use of metformin (P=0.037) and alcohol (P=0.012) was significantly associated with low levels of vitamin B12. Conclusion: Although the overall prevalence of B12 deficiency among patients with type 2 diabetes in Bahrain was low, patients at high risk of B12 deficiency, including metformin users and alcohol consumers, should be periodically screened to prevent the associated neurological and hematological sequela. Keywords: Bahrain, Cobalamin, Diabetes Mellitus, Primary Health Care, Vitamin B12 
546 |a EN 
690 |a Surgery 
690 |a RD1-811 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of the Bahrain Medical Society, Vol 36, Iss 1, Pp 1-7 (2024) 
787 0 |n https://www.bhmedsoc.com/jbms/view-article.php?Article_Unique_Id=JBMS29506 
787 0 |n https://doaj.org/toc/1015-6321 
787 0 |n https://doaj.org/toc/2960-6004 
856 4 1 |u https://doaj.org/article/c8ab8b2de83b4591b96e555cfc2db2aa  |z Connect to this object online.